Free Trial

inTEST Co. (NYSE:INTT) CEO Richard N. Jr. Grant Sells 2,688 Shares

inTEST logo with Computer and Technology background
Remove Ads

inTEST Co. (NYSE:INTT - Get Free Report) CEO Richard N. Jr. Grant sold 2,688 shares of the firm's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $7.48, for a total value of $20,106.24. Following the transaction, the chief executive officer now owns 162,241 shares in the company, valued at $1,213,562.68. This represents a 1.63 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

inTEST Stock Performance

Shares of NYSE:INTT traded down $0.12 during trading on Friday, reaching $7.75. The company had a trading volume of 34,984 shares, compared to its average volume of 41,094. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.26 and a quick ratio of 1.38. The stock's fifty day moving average price is $8.47 and its 200 day moving average price is $7.80. inTEST Co. has a fifty-two week low of $6.28 and a fifty-two week high of $14.35. The firm has a market capitalization of $95.91 million, a price-to-earnings ratio of 33.70 and a beta of 1.90.

inTEST (NYSE:INTT - Get Free Report) last announced its quarterly earnings data on Friday, March 7th. The company reported $0.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.14 by $0.09. inTEST had a net margin of 2.33% and a return on equity of 5.31%. During the same period in the previous year, the company posted $0.16 EPS. As a group, equities research analysts predict that inTEST Co. will post 0.41 EPS for the current year.

Remove Ads

Institutional Investors Weigh In On inTEST

A number of institutional investors have recently added to or reduced their stakes in INTT. XTX Topco Ltd purchased a new position in shares of inTEST during the 3rd quarter worth approximately $120,000. Jane Street Group LLC raised its position in inTEST by 9.0% in the fourth quarter. Jane Street Group LLC now owns 31,644 shares of the company's stock worth $272,000 after acquiring an additional 2,602 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in inTEST by 42.1% in the third quarter. JPMorgan Chase & Co. now owns 37,481 shares of the company's stock valued at $274,000 after acquiring an additional 11,102 shares during the period. Northern Trust Corp boosted its position in shares of inTEST by 8.2% during the 4th quarter. Northern Trust Corp now owns 40,328 shares of the company's stock worth $346,000 after purchasing an additional 3,048 shares in the last quarter. Finally, Russell Investments Group Ltd. boosted its position in shares of inTEST by 208.9% during the 4th quarter. Russell Investments Group Ltd. now owns 43,543 shares of the company's stock worth $374,000 after purchasing an additional 29,445 shares in the last quarter. Hedge funds and other institutional investors own 63.18% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts recently commented on INTT shares. Northland Securities upped their price target on shares of inTEST from $13.00 to $16.00 and gave the company an "outperform" rating in a research report on Wednesday, January 8th. Northland Capmk raised shares of inTEST from a "hold" rating to a "strong-buy" rating in a report on Thursday, January 2nd.

Get Our Latest Stock Report on INTT

About inTEST

(Get Free Report)

inTEST Corporation provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies.

Recommended Stories

Should You Invest $1,000 in inTEST Right Now?

Before you consider inTEST, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and inTEST wasn't on the list.

While inTEST currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

HIMS Stock Up 120%! More Growth Ahead?

HIMS Stock Up 120%! More Growth Ahead?

Hims & Hers (NYSE: HIMS) has skyrocketed 120% in just a month! Is it the next big disruptor in healthcare, or is it overpriced?

Recent Videos

 5 Stocks to BUY NOW in April 2025
3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads